BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

September 14, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

September 13, 2021 | News

HaemaLogiX raises $10 million to advance multiple myeloma treatments

HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor w...

September 09, 2021 | News

WHO South-East Asia countries resolve to reorient and strengthen health system

“Strong health systems that are primary health care-oriented, and which leave no one behind, create populations that are healthier, more productive a...

September 08, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

September 07, 2021 | News

TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund

TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings ...

September 06, 2021 | News

WHO SEA Region to discuss pandemic, rebuilding essential health services for UHC

The Seventy Fourth Regional Committee Session of WHO South-East Asia, the annual governing body meeting of WHO in the Region, is being hosted by Nepal from...

September 03, 2021 | News

Abbott to treat minimally invasive patients with aortic valve disease

The catheter aortic valve implantation (TAVI) procedure treats people with severe and symptomatic aortic snoosis whose surgical risk is considered high or ...

September 03, 2021 | News

Arctic Vision Obtains China IND Clearance for Presbyopia Treatment

The main objective of the Phase III clinical study is to evaluate the efficacy and safety of ARVN003 in temporary improvement of near vision in adults with...

September 03, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based compani...

September 02, 2021 | News

Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells

This collaborative research program aims to provide the cancer research community with a new gold standard workflow for single-cell sequencing by developin...

September 02, 2021 | News

P&G donates latest health innovation to help protect medical frontliners

The recent rise in cases has once again seen P&G's Force for Good program be a timely support to protect frontliners in hospitals, local government uni...

September 02, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

August 31, 2021 | News

Stay Connected